EMPE Diagnostics receives prestigious EU funding

Posted Posted in Uncategorized

Marie Skłodowska-Curie Actions Horizon 2020 RISE program has granted 1.3 million euros from the development of new methods of diagnosis and treatment of tuberculosis in a network project called Innovation in Tuberculosis – INNOVA4TB. We are happy to be a part of INNOVA4TB project, a collaborative initiative between 12 institutions from 6 countries (Spain, Sweden, […]

EMPE Diagnostics listed on the FIND’s Diagnostics Pipeline Tracker

Posted Posted in Uncategorized

Foundation for Innovative New Diagnostics, FIND. As stated on FINDs website “Diagnosis is the first step on the path to treatment and the foundation of disease control and prevention”. FIND focuses on providing diagnostic solutions where they are needed, provides guidelines, policies as well as providing understanding of the diagnostic value in the community. EMPE […]

EMPE presentation at WHO conference!

Posted Posted in Uncategorized

It was a great honor to represent Sweden and present our unique diagnostic solutions for the early-stage detection of bacterial infections and rapid genotyping of multidrug-resistant tuberculosis in the 2nd WHO conference held in New Delhi! A hearty thanks to all our Team Sweden, including Swedish Embassy, SweCare Foundation, Swedish Medtech, EMPE Diagnostics AB, ApiRays […]

EMPE Diagnostics has been recognised by SwedenBIO and has become a part of the Swedish Precision Medicine Industry Landscape.

Posted Posted in Uncategorized

We are overwhelmed for the recognition by SwedenBIO that launched the Precision Medicine – The Swedish Industry Guide 2018! SwedenBIO has launched a major new report representing the first effort to map the Swedish Precision Medicine Industry Landscape and showcase precision medicine companies in Sweden to the global life science community.